Expanded Access to Elotuzumab (Empliciti) for Multiple Myeloma
Clinical trial NCT03126617 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT03126617
- Sponsor
- Bristol-Myers Squibb
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.